New space recognises the need for more cost-effective bench space and flexible agreements for startups and spinouts
Sandwich, Kent, UK / 10th June 2024 / Discovery Park, Kent’s thriving life science community, has opened the doors to CoLab, a new shared lab facility. In partnership with Canterbury Christ Church University, CoLab has been specially designed for early-stage life science businesses, providing flexible bench space in a collaborative coworking environment.
Dr Cornelia Wilson, Senior Lecturer and Academic Laboratory Director at Canterbury Christ Church University, said…
Your Local Laboratory For Rapid Whole Plasmid Nanopore Sequencing Results
Located in Cambridge, Source Genomics is a leading provider of genomic services, processing all samples within our UK laboratory. With the introduction of our new SpeedREAD™ data delivery system for Whole Plasmid Nanopore Sequencing, we now offer unrivaled turnaround times.
Why Choose SpeedREAD™?
Unmatched Speed: Receive high-quality Whole Plasmid Nanopore Sequencing data within 24 hours of sample receipt.
Streamlined Process: Our innovative SpeedREAD™ system ensures a seamless and efficient data retrieval experience.…
Milestone payment follows successful target identification and validation in separate project under same collaboration
Cambridge, UK, 03 June 2024: PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first-in-class therapies, to transform patients’ lives.
PhoreMost and Boehringer Ingelheim entered a multi-project collaboration back in January 20201. In this second project, PhoreMost is…
CAMBRIDGE and NEWCASTLE, UK, 03 June 2024: DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN’s mechanistically relevant iPSC hepatocytes (Opti-Heps) with Atelerix's hydrogel preservation technology, which prevents loss of function and enables even sensitive samples to remain stable at ambient temperatures for up to two weeks.
In vitro liver models are laboratory-created liver cells or tissues that mimic the natural behaviour of…
The Femtech & Women’s Health edition of ‘Discovery Spark’ champions early stage businesses working to close the gender health gap
Sandwich, Kent, UK / 30th May 2024 / Discovery Park, Kent’s thriving life science and innovation community, announced the selection of 11 promising start-ups in FemTech & Women’s Health to join Discovery Spark, their growth and support programme for early stage businesses.
Igniting the growth of businesses solving women’s health challenges, the special female-focused edition of the Discovery Spark programme offers tailored mentoring and support…
Read June's eNews
Featuring:
Tony Jones intro direct from the BIO International Convention
Welcome to a Golden Age of ADCs (Plus More!)
Exploring the Evolving Landscape of Cell and Gene Therapy Dealmaking
Being A Superpower – Is It All About Science?
UK, Minnesota, North Carolina Top Trumps!
Building Life Science Adventures News
Sponsored by JMP - Accelerate Innovation with Design of Experiments (DOE) Webinar
Stay ahead with the latest in life science!
Three-storey, multi-occupancy building on track to provide fully fitted laboratory suites for fast-growing life science community within the Cambridge cluster
Cambridge, UK, 5th June 2024: Chesterford Research Park has announced the appointment of Glencar to undertake construction of its new Sidney Sussex Building, which is expected to deliver over 60,000 sq ft of laboratory and office space.
Owned by Aviva Investors, the global asset management business of Aviva plc, alongside Uttlesford District Council, Chesterford Research Park provides 250 acres of advanced laboratory and office space…
Bruntwood SciTech is announcing the launch of its new Life Science Accelerator programme at Alderley Park in a move aimed at supporting even greater innovation and economic growth in the region.
The new Life Science Accelerator has been designed to cater to the unique needs of early stage life science companies from across the UK, offering comprehensive support and specialist facilities to fuel their growth and development. Alderley Park, owned and operated by Bruntwood SciTech – a joint venture between Bruntwood, Legal & General and Greater Manchester Pension Fund – is…
Cambridge, 30th May 2024: Six life science start-ups looking to develop products and services to make a positive difference to healthcare have been selected for one of Europe’s top incubators based at the Babraham Research Campus in Cambridge – Accelerate@Babraham.
The package of support on offer which includes a year’s free lab space, £10k funding and access to an unrivalled network of experts, mentors and investors is always hotly contested and this year was no exception with the selection panel impressed by the strength of extremely high-quality applications.
Introducing the 2024 cohort…
Tokyo, Japan, Oxford and Cambridge, UK, 30 May 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) and PrecisionLife, the Causal AI precision medicine company, today announce the expansion of their strategic R&D partnership into auto-immune disorders with the potential to identify new drug targets for the treatment of complex, chronic conditions.
This is the latest in a series of collaborative agreements between Nxera and PrecisionLife, which began in 2022. The partnership aims to establish new drug targets and subsequently potential precision targeted therapies for auto-immune disorders,…